Back

prof. dr. H.J. (Josef) Vormoor

prof. dr. H.J. (Josef) Vormoor

Full Professor
prof. dr. H.J. (Josef) Vormoor
  • Imaging - research

Side Activities

Clinical Director - Prinses Máxima Centrum voor Kinderonclogie - 2018 - present

Research Output (13)

Leukemia suppressing normal bone marrow:how long does it last?

Blanco Mauricio Nicolas Ferrao, Belderbos Mirjam, Vormoor Hermann Josef 6 Apr 2023, In: Haematologica. 108 , p. 2891-2893 3 p.

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia

Verwaaijen Emma J, van der Torre Patrick, Vormoor Josef, Pieters Rob, Fiocco Marta, Hartman Annelies, van den Heuvel-Eibrink Marry M 3 Jan 2023, In: Cancers. 15

Have we made progress in taking care of adolescents and young adults with cancer?:Results of a European multi-professional survey

Bozovic Spasojevic Ivana, Ferrari Andrea, De Munter Johan, Gamble Ashley, Konsoulova-Kirova Assia, Rizvi Katie, Schneider Carina, Balsat Marie, Castleton Anna, Gofti-Laroche Leila, Kienesberger Anita, Timmermann Beate, Vormoor Josef, Saloustros Emmanouil, Stark Daniel P 2023, In: Tumori. 109 , p. 546-554 9 p.

Implementation of paediatric precision oncology into clinical practice:The Individualized Therapies for Children with cancer program 'iTHER'

Langenberg Karin P S, Meister Michael T, Bakhuizen Jette J, Boer Judith M, van Eijkelenburg Natasha K A, Hulleman Esther, Ilan Uri, Looze Eleonora J, Dierselhuis Miranda P, van der Lugt Jasper, Breunis Willemijn, Schild Linda G, Ober Kimberley, van Hooff Sander R, Scheijde-Vermeulen Marijn A, Hiemcke-Jiwa Laura S, Flucke Uta E, Kranendonk Mariette E G, Wesseling Pieter, Sonneveld Edwin, Punt Simone, Boltjes Arjan, van Dijk Freerk, Verwiel Eugene T P, Volckmann Richard, Hehir-Kwa Jayne Y, Kester Lennart A, Koudijs Marco M J, Waanders Esme, Holstege Frank C P, Vormoor H Josef, Hoving Eelco W, van Noesel Max M, Pieters Rob, Kool Marcel, Stumpf Miriam, Blattner-Johnson Mirjam, Balasubramanian Gnana P, Van Tilburg Cornelis M, Jones Barbara C, Jones David T W, Witt Olaf, Pfister Stefan M, Jongmans Marjolijn C J, Kuiper Roland P, de Krijger Ronald R, Wijnen Marc H W, den Boer Monique L, Zwaan C Michel, Kemmeren Patrick, Koster Jan, Tops Bastiaan B J, Goemans Bianca F, Molenaar Jan J Nov 2022, In: European Journal of Cancer. 175 , p. 311-325 15 p.

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

Tirtakusuma Ricky, Szoltysek Katarzyna, Milne Paul, Grinev Vasily V, Ptasinska Anetta, Chin Paulynn S, Meyer Claus, Nakjang Sirintra, Hehir-Kwa Jayne Y, Williamson Daniel, Cauchy Pierre, Keane Peter, Assi Salam A, Ashtiani Minoo, Kellaway Sophie G, Imperato Maria R, Vogiatzi Fotini, Schweighart Elizabeth K, Lin Shan, Wunderlich Mark, Stutterheim Janine, Komkov Alexander, Zerkalenkova Elena, Evans Paul, McNeill Hesta, Elder Alex, Martinez-Soria Natalia, Fordham Sarah E, Shi Yuzhe, Russell Lisa J, Pal Deepali, Smith Alex, Kingsbury Zoya, Becq Jennifer, Eckert Cornelia, Haas Oskar A, Carey Peter, Bailey Simon, Skinner Roderick, Miakova Natalia, Collin Matthew, Bigley Venetia, Haniffa Muzlifah, Marschalek Rolf, Harrison Christine J, Cargo Catherine A, Schewe Denis, Olshanskaya Yulia, Thirman Michael J, Cockerill Peter N, Mulloy James C, Blair Helen J, Vormoor Josef, Allan James M, Bonifer Constanze, Heidenreich Olaf, Bomken Simon 27 Oct 2022, In: Blood. 140 , p. 1875-1890 16 p.

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Dekker Linde, Calkoen Friso G., Jiang Yilin, Blok Hilly, Veldkamp Saskia R., De Koning Coco, Spoon Maike, Admiraal Rick, Hoogerbrugge Peter, Vormoor Britta, Vormoor H. Josef, Visscher Henk, Bierings Marc, Van Der Vlugt Marieke, Van Tinteren Harm, Nijstad A. Laura, Huitema Alwin D.R., Van Der Elst Kim C.M., Pieters Rob, Lindemans Caroline A., Nierkens Stefan 12 Apr 2022, In: Blood Advances. 6 , p. 1969-1976 8 p.

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex):study protocol for an international, parallel-group, dose-finding with expansion phase I/II trial

Menne Tobias, Slade Daniel, Savage Joshua, Johnson Sarah, Irving Julie, Kearns Pamela, Plummer Ruth, Shenton Geoff, Veal Gareth J, Vormoor Britta, Vormoor Josef, Billingham Lucinda 4 Mar 2022, In: BMJ Open. 12

Targeted inhibitors and antibody immunotherapies:Novel therapies for paediatric leukaemia and lymphoma

Brivio Erica, Baruchel André, Beishuizen Auke, Bourquin Jean-Pierre, Brown Patrick A, Cooper Todd, Gore Lia, Kolb E Anders, Locatelli Franco, Maude Shannon L, Mussai Francis J, Vormoor-Bürger Britta, Vormoor Josef, von Stackelberg Arend, Zwaan C Michel Mar 2022, In: European Journal of Cancer. 164 , p. 1-17 17 p.

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

van der Zwet Jordy C G, Buijs-Gladdines Jessica G C A M, Cordo' Valentina, Debets Donna O, Smits Willem K, Chen Zhongli, Dylus Jelle, Zaman Guido J R, Altelaar Maarten, Oshima Koichi, Bornhauser Beat, Bourquin Jean-Pierre, Cools Jan, Ferrando Adolfo A, Vormoor Josef, Pieters Rob, Vormoor Britta, Meijerink Jules P P Dec 2021, In: Leukemia. 35 , p. 3394-3405 12 p.

Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia

Shi Yuzhe, Beckett Melanie C, Blair Helen J, Tirtakusuma Ricky, Nakjang Sirintra, Enshaei Amir, Halsey Christina, Vormoor Josef, Heidenreich Olaf, Krippner-Heidenreich Anja, van Delft Frederik W 1 Apr 2021, In: Haematologica. 106 , p. 1056-1066 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not